Last update 01 Nov 2024

Actavis Laboratories UT, Inc.

Subsidiary Company|
Utah, United States

Overview

Tags

Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
A1R x A2aR x COX x GABAA receptor x Opioid receptors1

Related

2
Drugs associated with Actavis Laboratories UT, Inc.
Aspirin/Caffeine/Codeine Phosphate/Butalbital
Target
A1R x A2aR x COX x GABAA receptor x Opioid receptors
Mechanism
A1R antagonists [+4]
Active Org.
Actavis Laboratories UT, Inc.
Originator Org.
Allergan Ltd. (Ireland)
Active Indication
Tension-Type Headache
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Oct 1990
Progesterone
Target
PR
Mechanism
PR modulators
Active Org.
Fresenius Kabi Austria GmbHFresenius Kabi Austria GmbH [+20]
Originator Org.
Mochida Pharmaceutical Co., Ltd.Mochida Pharmaceutical Co., Ltd. [+1]
Active Indication
Endometrial Hyperplasia [+16]
Inactive Indication
Abnormal uterine bleeding [+10]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date25 Jan 1956
100 Clinical Results associated with Actavis Laboratories UT, Inc.
Login to view more data
0 Patents (Medical) associated with Actavis Laboratories UT, Inc.
Login to view more data
100 Deals associated with Actavis Laboratories UT, Inc.
Login to view more data
100 Translational Medicine associated with Actavis Laboratories UT, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
1
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free